panel
shown
copi
rna
per
reaction
infecti
dose
id
per
reaction
cultur
virus
crossreact
observ
test
human
clinic
specimen
cultur
virus
posit
human
season
b
influenza
virus
cdc
rrtpcr
swine
flu
panel
distribut
public
health
laboratori
unit
swine
influenza
common
contagi
respiratori
diseas
pig
caus
influenza
virus
first
swine
influenza
viru
siv
also
refer
classic
siv
viru
isol
unit
state
circul
pig
least
year
triplereassort
siv
trsiv
subtyp
contain
gene
segment
human
avian
swine
influenza
virus
found
circul
north
american
n
swine
popul
genet
analysi
show
particular
nucleoprotein
np
gene
trsiv
inherit
classic
siv
origin
hemagglutinin
ha
neuraminidas
na
gene
differ
gene
close
relat
gene
classic
siv
recent
isol
human
avian
virus
fig
find
provid
compel
evid
trsiv
enhanc
abil
acquir
novel
surfac
glycoprotein
thu
caus
public
health
concern
potenti
pandem
threat
although
siv
regularli
caus
ill
pig
commonli
infect
human
sporad
case
human
infect
report
mani
countri
total
case
human
infect
siv
detect
unit
state
isol
singl
case
infect
histori
direct
indirect
exposur
pig
prior
onset
ill
two
case
limit
humantohuman
transmiss
could
exclud
sporad
human
infect
siv
detect
passiv
surveil
human
influenza
small
subset
influenza
aposit
sampl
comprehens
analyz
unclear
mani
human
case
siv
occur
undetect
thu
realtim
revers
transcriptas
pcr
rrtpcr
procedur
design
optim
influenza
divis
center
diseas
control
prevent
cdc
allow
rapid
sensit
specif
detect
case
april
first
human
case
pandem
pdm
influenza
detect
use
cdc
rrtpcr
procedur
origin
design
detect
human
case
trsiv
infect
novel
influenza
viru
first
found
unit
state
mexico
never
previous
isol
complet
genom
analysi
determin
pdm
influenza
viru
inherit
gene
n
trsiv
viru
eurasian
avianlik
siv
fig
paper
describ
develop
analyt
perform
cdc
rrtpcr
swine
flu
panel
base
initi
cdc
rrtpcr
procedur
detect
n
trsiv
respons
influenza
pandem
cdc
rrtpcr
swine
flu
panel
requir
reagent
suppli
distribut
global
implement
rapid
test
specimen
pdm
influenza
viru
influenza
virus
test
studi
grown
high
titer
either
madindarbi
canin
kidney
mdck
cell
embryon
chicken
egg
ece
infecti
viru
cultur
supernat
allanto
fluid
measur
determin
number
tissu
cultur
infecti
dose
per
millilit
tcid
ml
number
egg
infecti
dose
per
millilit
eid
ml
respect
clinic
specimen
nasal
wash
nasal
swab
nasopharyng
swab
throat
swab
lower
respiratori
tract
specimen
includ
studi
receiv
us
state
local
public
health
laboratori
well
foreign
laboratori
april
june
rna
extract
viral
rna
extract
l
viru
isol
clinic
specimen
elut
volum
use
magna
pure
compact
rna
isol
kit
protocol
magna
pure
compact
instrument
roch
appli
scienc
accord
manufactur
instruct
cdc
rrtpcr
swine
flu
panel
primer
probe
cdc
rrtpcr
swine
flu
panel
includ
four
oligonucleotid
primer
probe
set
univers
influenza
infa
swine
influenza
swinfa
swine
rnase
p
rp
design
detect
character
influenza
virus
human
specimen
assay
design
three
assay
infa
swinfa
must
posit
indic
detect
n
siv
pdm
viru
result
one
two
three
assay
posit
would
inconclus
would
requir
character
infa
assay
design
univers
detect
matrix
gene
influenza
virus
swinfa
assay
design
univers
detect
np
gene
n
siv
subtyp
differenti
siv
subtyp
human
season
influenza
virus
assay
design
specif
detect
ha
gene
classic
siv
n
trsiv
bear
classic
subtyp
well
pdm
influenza
viru
differenti
human
season
influenza
rp
assay
detect
human
rnase
p
gene
use
human
clinic
specimen
measur
qualiti
specimen
well
indic
nucleic
acid
extract
adequ
clinic
specimen
oligonucleotid
primer
probe
design
base
avail
nucleotid
sequenc
data
genbank
databas
nation
center
biotechnolog
inform
ncbi
nih
influenza
sequenc
databas
lo
alamo
nation
laboratori
lanl
global
initi
share
avian
influenza
data
gisaid
nucleotid
blast
search
ncbi
analysi
use
verifi
primer
probe
sequenc
specif
avoid
potenti
nonspecif
reactiv
primer
probe
design
anneal
temperatur
approxim
respect
use
primerexpress
softwar
appli
biosystem
foster
citi
ca
duallabel
hydrolysi
probe
label
end
report
dye
fam
quench
blackhol
quencher
either
end
intern
modifi
residu
end
prevent
probe
extens
taq
polymeras
biosearch
technolog
inc
primer
dualli
label
taqman
hydrolysi
probe
synthes
biosearch
technolog
inc
novato
ca
see
tabl
supplement
materi
rrtpcr
condit
reaction
condit
rrtpcr
base
food
drug
administr
fda
clear
cdc
human
influenza
viru
realtim
rtpcr
detect
character
panel
cdc
rrtpcr
flu
panel
cdc
rrtpcr
flu
panel
contain
primer
probe
set
detect
influenza
viru
matrix
gene
cdc
rrtpcr
swine
flu
panel
order
determin
optim
anneal
extens
temperatur
thermal
gradient
analysi
perform
triplic
use
biorad
system
extract
rna
pdm
influenza
viru
strain
tabl
see
also
fig
supplement
materi
thermocycl
rrtpcr
condit
follow
min
taq
activ
min
cycl
annealingextens
step
temperatur
rang
three
assay
show
compar
level
perform
anneal
temperatur
rang
final
reaction
anneal
temperatur
set
maximum
optim
anneal
temperatur
use
accommod
potenti
nucleotid
mismatch
primerprob
region
due
viru
evolut
pcr
paramet
cdc
rrtpcr
swine
flu
panel
optim
use
invitrogen
superscript
iii
platinum
onestep
quantit
rtpcr
kit
life
technolog
stratagen
biorad
appli
biosystem
ab
fast
dx
realtim
pcr
system
rrtpcr
perform
total
reaction
volum
l
final
primer
probe
reaction
concentr
respect
analyt
perform
data
clinic
specimen
data
collect
use
ab
fast
dx
realtim
pcr
instrument
reaction
effici
primer
probe
set
infa
swinfa
assay
determin
test
serial
tabl
lod
cdc
rrtpcr
swine
flu
panel
determin
accord
lowest
concentr
three
assay
infa
swinfa
gave
posit
result
lod
determin
viru
concentr
id
ml
three
virus
test
correl
id
per
reaction
lreaction
similarli
quantifi
synthet
rna
pdm
influenza
viru
armor
rna
quant
asuragen
inc
test
duplic
tabl
determin
minimum
rna
copi
number
detect
assay
lod
infa
swinfa
assay
found
copi
rna
per
reaction
cutoff
c
valu
cdc
swine
flu
panel
determin
domest
human
diagnost
test
purpos
condit
fda
emerg
use
author
unit
state
cutoff
valu
base
upon
data
lod
analysi
consist
cutoff
valu
previous
establish
cdc
rrtpcr
flu
panel
analyt
specif
inclus
assay
specif
demonstr
test
pdm
influenza
virus
propag
either
mdck
cell
cultur
ece
virus
dilut
approxim
limit
detect
assay
approxim
id
ml
extract
rna
test
triplic
expect
virus
test
posit
infa
swinfa
assay
low
viru
concentr
tabl
assess
perform
cdc
rrtpcr
swine
flu
panel
variou
siv
isol
pig
human
extract
rna
cultur
siv
test
tabl
two
classic
siv
subtyp
virus
five
n
trsiv
subtyp
virus
gave
posit
result
infa
swinfa
assay
one
n
subtyp
viru
whose
ha
origin
human
influenza
viru
one
n
subtyp
viru
posit
infa
swinfa
assay
neg
assay
one
eurasianlineag
siv
subtyp
viru
infa
posit
swinfa
neg
test
result
concord
expect
result
analyt
specif
exclus
order
demonstr
absenc
crossreact
common
human
respiratori
pathogen
exclus
test
perform
tabl
supplement
materi
influenza
virus
infa
posit
swinfa
neg
expect
influenza
b
virus
neg
three
assay
analyt
specif
demonstr
test
noninfluenza
viru
strain
bacteri
organ
commonli
present
nasopharynx
region
human
respiratori
tract
crossreact
observ
noninfluenza
organ
test
high
titer
see
tabl
supplement
materi
extract
rna
nonsiv
anim
influenza
virus
also
test
high
viru
titer
see
tabl
supplement
materi
expect
nonsiv
anim
influenza
virus
test
infa
posit
neg
although
virus
posit
swinfa
assay
howev
three
assay
posit
nonsiv
anim
influenza
viru
result
would
consid
inconclus
requir
test
total
respiratori
specimen
test
presenc
influenza
viru
us
public
health
laboratori
may
februari
order
monitor
perform
cdc
rrtpcr
swine
flu
panel
us
public
health
laboratori
instruct
send
human
clinic
specimen
nasal
wash
nasal
swab
nasopharyng
swab
throat
swab
lower
respiratori
tract
specimen
inconclus
test
result
cdc
influenza
divis
test
character
fig
cdc
influenza
divis
test
result
clinic
specimen
receiv
due
inconclus
result
specimen
infa
assay
c
valu
higher
test
cdc
indic
low
viral
concentr
near
limit
detect
assay
averag
infa
c
valu
standard
deviat
sd
specimen
test
cdc
found
posit
pdm
influenza
viru
inconclus
invalid
influenza
viru
rp
marker
test
neg
neg
remain
specimen
receiv
due
inconclus
result
infa
test
c
valu
indic
viru
titer
specimen
well
limit
detect
assay
speciment
found
posit
pdm
influenza
viru
rrtpcr
genet
sequenc
character
eighteen
specimen
receiv
due
inconclus
result
posit
multipl
influenza
virus
suggest
coinfect
two
influenza
viru
strain
upon
genet
character
specimen
contain
season
trival
live
attenu
influenza
viru
vaccin
laiv
found
posit
pdm
laiv
specimen
contain
pdm
laiv
test
use
cdc
rrtpcr
swine
flu
panel
demonstr
inconclus
result
posit
infa
neg
swinfa
number
human
clinic
specimen
receiv
due
inconclus
result
posit
infa
swinfa
neg
subsequ
confirm
posit
pdm
influenza
viru
bidirect
genet
sequenc
analysi
comparison
nucleotid
sequenc
ha
gene
determin
directli
clinic
specimen
confirm
three
nucleotid
mismatch
within
probe
region
assay
fig
howev
consist
pattern
conserv
nucleotid
mutat
whose
circul
persist
could
identifi
fact
among
ha
gene
pdm
influenza
virus
avail
gisaid
databas
august
virus
genet
chang
identifi
cdc
rrtpcr
swine
flu
panel
highli
sensit
specif
assay
detect
character
n
trsiv
contain
ha
subtyp
well
pdm
influenza
virus
assay
shown
highli
sensit
detect
low
id
ml
pdm
classic
trsiv
virus
correspond
approxim
id
per
reaction
similarli
assay
shown
detect
copiesreact
pdm
influenza
viru
rna
also
cdc
rrtpcr
swine
flu
panel
demonstr
highli
specif
character
n
siv
subtyp
well
pdm
influenza
virus
expect
test
classic
siv
n
trsiv
virus
posit
three
assay
test
n
trsiv
n
trsiv
virus
infa
swinfa
posit
neg
sinc
latter
viru
subtyp
possess
ha
antigen
inherit
human
season
virus
cdc
rrtpcr
swine
flu
panel
show
crossreact
among
three
assay
common
noninfluenza
viru
respiratori
pathogen
influenza
b
cultur
virus
influenza
b
virusposit
clinic
specimen
crossreact
observ
swinfa
assay
use
test
human
season
influenza
virus
crossreact
observ
assay
test
highli
pathogen
avian
influenza
hpai
virus
anim
influenza
virus
differ
subtyp
howev
swinfa
assay
demonstr
crossreact
hpai
virus
nonsiv
anim
influenza
virus
test
studi
due
similar
primer
probe
sequenc
virus
sinc
none
nonsiv
anim
influenza
viru
test
posit
three
assay
cdc
rrtpcr
swine
flu
panel
result
would
consid
inconclus
requir
genet
analysi
conclus
posit
result
observ
broad
rang
influenza
virus
nonswin
origin
well
respiratori
pathogen
thu
demonstr
analyt
specif
cdc
rrtpcr
swine
flu
panel
soon
first
confirm
well
establish
influenza
virus
evolv
rapidli
capabl
adapt
gener
divers
genet
mutat
genet
reassort
particularli
follow
emerg
novel
pandem
strain
human
mutat
rate
reassort
capabl
pdm
influenza
virus
initi
unknown
imper
monitor
perform
cdc
rrtpcr
swine
flu
panel
pandem
determin
effect
genet
chang
due
mutat
reassort
might
affect
assay
perform
therefor
us
public
health
laboratori
advis
submit
clinic
specimen
inconclus
result
cdc
influenza
divis
test
character
among
submit
six
human
specimen
contain
laiv
give
posit
test
result
infa
assay
neg
result
swinfa
assay
reactiv
expect
sinc
laiv
reassort
viru
contain
six
intern
gene
segment
deriv
coldadapt
master
donor
viru
aann
ha
na
gene
segment
recommend
vaccin
viru
pdm
genet
analysi
clinic
specimen
receiv
pandem
cdc
due
inconclus
result
obtain
local
laboratori
reveal
virus
variou
pattern
three
mutat
bind
region
probe
caus
decreas
reactiv
assay
howev
virus
similar
mutat
account
sequenc
submit
gisaid
databas
septemb
thu
indic
vast
major
pdm
influenza
virus
detect
three
assay
cdc
rrtpcr
swine
flu
panel
cdc
rrtpcr
swine
flu
panel
serv
effect
emerg
tool
throughout
pandem
rapid
detect
pdm
viru
mani
countri
essenti
emerg
respons
implement
effort
updat
optim
procedur
reagent
detect
pdm
influenza
virus
human
clinic
sampl
still
necessari
order
address
potenti
risk
emerg
variant
similar
reactiv
characterist
well
elimin
crossreact
swinfa
assay
avian
anim
virus
